Skip to content
ppharmaranks
Menu

Best Endothelin Receptor Antagonist for hypertension, pulmonary

Top-rated pick: Letairis — pharmaranks score 70/100, the highest of the 6 Endothelin Receptor Antagonist drugs used for hypertension, pulmonary, ranked by our independent FDA recall-safety score. Compare them with all treatments for hypertension, pulmonary or the full Endothelin Receptor Antagonist class. Not medical advice — always consult a professional.

Quick answer: Of the 6 endothelin receptor antagonist drugs we rate for hypertension, pulmonary, 2 are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for hypertension, pulmonary; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

How endothelin receptor antagonist work

Endothelin receptor antagonists block endothelin-1, a natural substance that powerfully tightens blood vessels. By stopping it from acting on its receptors, these drugs let vessels relax and widen, lowering pressure in the lung arteries in conditions like pulmonary arterial hypertension.

Source: Bosentan - StatPearls - NCBI Bookshelf

Top endothelin receptor antagonist for hypertension, pulmonary: 1. Letairis · 2. Ambrisentan · 3. Bosentan

Best-rated Endothelin Receptor Antagonist for hypertension, pulmonary, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$256View →
266/100$256View →
366/100View →
466/100View →
5Not yet ratedView →
6Not yet ratedView →

Full ranking · 6 drugs

#1 of 4 in Endothelin Receptor Antagonist

letairis

Boxed warning

PrescriptionFDA-sourced

70/100

Letairis (Ambrisentan) is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

(4 data points)
endothelin receptor antagonisthypertension, pulmonary

Pharmacy pays

~$255.61 /30

View details →
#2 of 4 in Endothelin Receptor Antagonist

ambrisentan

Boxed warning

PrescriptionFDA-sourced

66/100

Ambrisentan is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

(44 data points)
endothelin receptor antagonisthypertension, pulmonary

Pharmacy pays

~$255.61 /30

View details →
#2 of 4 in Endothelin Receptor Antagonist

bosentan

Boxed warning

PrescriptionFDA-sourced

66/100

Bosentan is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

(44 data points)
endothelin receptor antagonisthypertension, pulmonary

Price varies

View details →
#2 of 4 in Endothelin Receptor Antagonist

macitentan

Boxed warning

PrescriptionFDA-sourced

66/100

Macitentan is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

(42 data points)
endothelin receptor antagonisthypertension, pulmonary

Price varies

View details →

opsumit

Boxed warning

PrescriptionFDA-sourced

New

Opsumit (Macitentan) is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

endothelin receptor antagonisthypertension, pulmonary

Price varies

View details →

tracleer

Boxed warning

PrescriptionFDA-sourced

New

Tracleer (Bosentan) is an endothelin receptor antagonist used to treat Pulmonary Hypertension.

endothelin receptor antagonisthypertension, pulmonary

Price varies

View details →

Frequently asked

What is the best endothelin receptor antagonist for hypertension, pulmonary?
By our independent recall-safety rating — not an efficacy measure — letairis ranks highest among Endothelin Receptor Antagonist drugs used for hypertension, pulmonary. Always consult a professional.
Which endothelin receptor antagonist drugs treat hypertension, pulmonary?
pharmaranks lists 6 Endothelin Receptor Antagonist products used for hypertension, pulmonary, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.